News Focus
News Focus
Followers 280
Posts 31200
Boards Moderated 0
Alias Born 07/06/2012

Re: MazelMan post# 227403

Saturday, 07/25/2015 6:24:25 AM

Saturday, July 25, 2015 6:24:25 AM

Post# of 347009
19 months into Phase 3, MSK collaboration and Peregrine expands trials. Sounds like another 6 months to me before the tipping point begins- second look in. Let's hope the positive tone during the recent CC tells the real story.

In the interim, I plan on picking up additional shares.

Has any other Biotech company in the history of cancer treatment gotten this far along in a Phase 3 trial without a partnership?

Fear Uncertainty and Doubt FUD It Ain't Going To Work Here Anymore. Notice the lack of question mark.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y